Search results
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 7 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
Tirzepatide Significantly Reduces Sleep Disruptions
Medscape· 2 days agoThe diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in ...
EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offers new standard for MCL
Pharmaceutical Technology via Yahoo Finance· 7 days agoCovid-19-related events and pneumonia were more common in the ABR group, resulting in a higher...
What's the MACE Risk With Moderate to Severe Eczema?
Medscape· 5 days agoThe findings contrast with the expectation that increased systemic inflammation in moderate to severe AD would correspond with a higher incidence of...
Study shows 12% long-COVID prevalence following Omicron infection
Center for Infectious Disease Research and Policy· 7 days agoThe odds ratio of any persistent symptoms was more than double in COVID-19 patients.
Fewer people died in Colorado last year, but state’s death rate remains elevated since pandemic
Denver Post· 1 day agoFewer Coloradans died in 2023 than in the previous year, but the state still lost more people than...
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea
Associated Press· 3 days agoEli Lilly and Co., the drug’s maker who paid for the research, has asked the Food and Drug...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 4 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Upadacitinib User Survey Confirms Eczema Clinical Data
Medscape· 4 days agoIn a survey of adults with moderate to severe AD participating in a patient support program for upadacitinib in the United States, 86.8% reported that their ...
U.S. gun injury rates in 2023 again exceeded pre-pandemic levels
UPI· 3 days agoFor the fourth year in a row, rates of gun injuries stayed above levels seen before the COVID-19...